triazoles has been researched along with Leukemia L 1210 in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (50.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 5 (31.25) | 29.6817 |
2010's | 2 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cho, B; Chung, NG; Jang, PS; Jeong, DC; Kim, HK; Lee, DH | 1 |
Cipak, L; Jantova, S; Repicky, A | 1 |
Cao, TY; Chen, YS; Duan, NN; Hu, GQ; Huang, WL; Wang, GQ; Wang, W; Wen, XY; Xie, SQ; Yin, J | 1 |
Balzarini, J; Benhida, R; Bougrin, K; El Akri, K; Faraj, A | 1 |
Dong, XL; Hu, GQ; Huang, WL; Xie, SQ | 1 |
Bacon, PE; Cory, JG; Sato, A | 1 |
Chiang, PK; Cory, JG; De Clercq, E; Kim, IK; Olsson, RA; Schneller, SW; Thompson, RD | 1 |
Dias Selassie, C; Khwaja, TA; Lien, EJ | 1 |
Hori, Y; Zhou, B | 1 |
Borch, RF; Freel Meyers, CL; Hong, L; Joswig, C | 1 |
Chikuma, M; Komeda, S; Lutz, M; Reedijk, J; Sato, T; Spek, AL; Yamanaka, Y | 1 |
Dave, C; Paul, MA; Rustum, YM | 1 |
Fuji, H; Mihich, E | 1 |
Brockman, RW | 1 |
Adamson, RH; Hahn, MA | 1 |
Florvall, L | 1 |
1 review(s) available for triazoles and Leukemia L 1210
Article | Year |
---|---|
Biochemical aspects of drug combinations.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Bleomycin; Camptothecin; Cell Division; Cytarabine; Deferoxamine; Diamines; DNA, Neoplasm; Doxorubicin; Drug Therapy, Combination; Leukemia L1210; Macromolecular Substances; Mice; Neoplasms; Neoplasms, Experimental; Nitrosourea Compounds; Purine Nucleotides; Ribonucleotide Reductases; Thioguanine; Triazoles | 1974 |
15 other study(ies) available for triazoles and Leukemia L 1210
Article | Year |
---|---|
Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzoates; Cell Line, Tumor; Chlorides; Crosses, Genetic; Deferasirox; Deferoxamine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; fas Receptor; Female; Ferric Compounds; Gene Expression Regulation, Leukemic; Iron; Iron Chelating Agents; Iron Overload; Iron-Dextran Complex; Leukemia L1210; Liver; Lymphoma, T-Cell; Mice; Mice, Inbred Strains; Neoplasm Proteins; Triazoles; Tumor Burden | 2013 |
3-(5-Nitro-2-thienyl)-9-chloro-5-morpholin-4-yl[1,2,4]triazolo[4,3-c]quinazoline induces ROS-mitochondrial mediated death signaling and activation of p38 MAPK in murine L1210 leukemia cells.
Topics: Animals; Apoptosis; Caspase 3; Cytochromes c; Enzyme Activation; JNK Mitogen-Activated Protein Kinases; Leukemia L1210; Membrane Potential, Mitochondrial; Mice; Mitochondria; Molecular Structure; p38 Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Quinazolines; Reactive Oxygen Species; Signal Transduction; Triazoles | 2009 |
[Part IV. Synthesis and antitumor evaluation of s-triazolothiadiazines and pyrazolo s-triazoles derived from ciproxacin].
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; CHO Cells; Ciprofloxacin; Cricetinae; Cricetulus; Fluoroquinolones; HL-60 Cells; Humans; Inhibitory Concentration 50; Leukemia L1210; Mice; Structure-Activity Relationship; Thiadiazines; Triazoles | 2012 |
Efficient synthesis and in vitro cytostatic activity of 4-substituted triazolyl-nucleosides.
Topics: Animals; Cell Line, Tumor; Cytostatic Agents; Humans; Leukemia L1210; Mice; Nucleosides; Structure-Activity Relationship; Triazoles | 2007 |
[Synthesis and antitumor activity of anthracene-9-carbaldehyde amino-s-triazole Schiff-bases with side-chain of S-acetic acid].
Topics: Acetic Acid; Animals; Anthracenes; Antineoplastic Agents; CHO Cells; Cricetinae; Cricetulus; HL-60 Cells; Humans; Leukemia L1210; Mice; Molecular Structure; Schiff Bases; Triazoles | 2008 |
Studies on the differential mechanisms of inhibition of ribonucleotide reductase by specific inhibitors of the non-heme iron subunit.
Topics: Anaerobiosis; Animals; Catalase; Cell Division; Cells, Cultured; Deferoxamine; Guanazole; Humans; Hydroxyurea; Isoenzymes; Isoquinolines; Leukemia L1210; Peroxidase; Peroxidases; Pyrazoles; Quinolines; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; Triazoles | 1984 |
Biological activity and a modified synthesis of 8-amino-3-beta-D-ribofuranosyl-1,2,4-triazolo[4,3-a]pyrazine, an isomer of formycin.
Topics: Adenosine Deaminase; Adenosylhomocysteinase; Animals; Antibiotics, Antineoplastic; Cell Division; Dogs; Formycins; Hydrolases; Isomerism; Leukemia L1210; Mice; Pyrazines; Triazoles; Vasodilation | 1984 |
Synthesis and evaluation of guanazole prodrugs as antineoplastic agents.
Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Guanazole; Hydrolysis; In Vitro Techniques; Leukemia L1210; Molecular Weight; Solubility; Spectrophotometry, Ultraviolet; Triazoles | 1981 |
[Modification effects of AK-2123 on adriamycin to mouse leukemic cells].
Topics: Animals; Doxorubicin; Drug Synergism; Leukemia L1210; Mice; Triazoles; Tumor Cells, Cultured | 1994 |
Synthesis and biological activity of novel 5-fluoro-2'-deoxyuridine phosphoramidate prodrugs.
Topics: Amides; Animals; Antimetabolites, Antineoplastic; Cell Division; Drug Screening Assays, Antitumor; Floxuridine; Furans; Inhibitory Concentration 50; Leukemia L1210; Magnetic Resonance Spectroscopy; Mice; Phosphoric Acids; Prodrugs; Triazoles; Tumor Cells, Cultured | 2000 |
A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole.
Topics: Animals; Antineoplastic Agents; Cisplatin; Crystallography, X-Ray; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Guanine; Hydrogen-Ion Concentration; Isomerism; Leukemia L1210; Mice; Nuclear Magnetic Resonance, Biomolecular; Organoplatinum Compounds; Platinum; Triazoles; Tumor Cells, Cultured | 2002 |
Studies on the selective toxicity of guanazole in mice.
Topics: Animals; Depression, Chemical; DNA; Female; Guanazole; In Vitro Techniques; Leukemia L1210; Mice; Mice, Inbred DBA; Ribonucleotides; RNA; Spleen; Thymidine; Triazoles; Uridine | 1978 |
Selection for high immunogenicity in drug-resistant sublines of murine lymphomas demonstrated by plaque assay.
Topics: Animals; Antibodies, Neoplasm; Antibody-Producing Cells; Antigens, Neoplasm; Antineoplastic Agents; Cell Line; Cytotoxicity Tests, Immunologic; Diamines; Drug Resistance; Female; Glyoxal; Guanine; Hemolytic Plaque Technique; Histocompatibility Antigens; Hydrazones; Leukemia L1210; Mice; Mice, Inbred DBA; Spleen; Thymus Gland; Triazoles; Urea | 1975 |
Pharmacology of 3,5-diamino-1,24-triazole (guanazole). 1. Antitumor activity of guanazole.
Topics: Amines; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Cyclophosphamide; Cytarabine; Depression, Chemical; Female; Hydroxyurea; In Vitro Techniques; Leukemia L1210; Leukemia, Experimental; Lymphoma, Large B-Cell, Diffuse; Male; Mast-Cell Sarcoma; Methotrexate; Mice; Neoplasms, Experimental; Nitrosourea Compounds; Plasmacytoma; Structure-Activity Relationship; Triazoles | 1972 |
Some antitumor agents derived from benzaldehyde nitrogen mustards.
Topics: Animals; Antineoplastic Agents; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Hydrazines; Leukemia L1210; Mice; Neoplasms, Experimental; Nitrogen Mustard Compounds; Rats; Triazoles | 1970 |